Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab
Clinical trial update indicates the study examining circulating tumor DNA alterations in non-small cell lung cancer patients treated with pe…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG [Phase 2]
A Phase 2 clinical trial is evaluating an imaging radiotracer, [18F]-FARAG, in patients with advanced non-small cell lung cancer undergoing …
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Test-retest Evaluation of [18F]F-AraG PET [Phase 2]
A Phase 2 clinical trial evaluating the test-retest reliability of the [18F]F-AraG PET tracer in non-small cell lung cancer is currently rec…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation [Phase 2]
Phase 2 clinical trial update exploring treatment strategies and survival outcomes for non-small cell lung cancer with oncogenic mutations; …
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge [Phase 2]
A Phase 2 clinical trial evaluating sequencing of osimertinib followed by chemotherapy in EGFR-mutated non-small cell lung cancer, focusing …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC [Phase 2]
A Phase 2 neoadjuvant trial in resectable stage IIA-IIIB non-small cell lung cancer evaluating Sintilimab (PD-1 inhibitor) plus Anlotinib an…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial at Vanderbilt-Ingram Cancer Center is evaluating split-course adaptive radiation therapy with pembrolizumab, with or…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC) [NA]
This clinical trial update describes the SELTIC study comparing segmentectomy versus lobectomy for T1C non-small cell lung cancer; the trial…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 neoadjuvant study of Vebreltinib for MET-altered, potentially resectable non-small cell lung cancer (stage IIIA-IIIB, N2); the trial…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer [NA]
A clinical trial update describing the safety and efficacy evaluation of BST08 in advanced non-small cell lung cancer, with the study curren…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. [Phase 3]
A Phase 3 clinical trial is evaluating QL1706 in combination with platinum-containing chemotherapy as adjuvant therapy for stage II-IIIB non…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study [NA]
A multicenter randomized trial is comparing sublobar resection with lobectomy for small non-small cell lung cancers (2 cm or smaller) and is…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer [Phase 1, Phase 2]
Clinical trial update on tumor-infiltrating lymphocyte therapy combined with pembrolizumab for advanced or metastatic lung cancer (Phase 1/P…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Phase I Study of CFT8919 in Patients With Advanced NSCLC [Phase 1]
A Phase I clinical trial of CFT8919 in patients with advanced non-small cell lung cancer carrying EGFR mutations; the study status is not ye…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance [Phase 2]
A Phase 2 trial is evaluating maintenance therapy with a third-generation EGFR-TKI plus Anlotinib for non-small cell lung cancer with small …
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC [Phase 1, Phase 2]
An early-phase clinical trial evaluating AK112 in combination with platinum-based chemotherapy for EGFR/ALK/ROS1-positive non-small cell lun…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
This clinical trial update reports results from a study assessing detection of circulating tumor cells in patients with non-small cell lung …
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Microplastics in the Human Respiratory System
This update covers a clinical trial investigating microplastics in the human respiratory system. The study relates to non-small cell lung ca…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Cancer Patient Remote Monitoring for Timely Communication Study
This clinical trial update describes a remote monitoring study intended to improve timely communication for cancer patients with stage IV no…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) [NA]
Clinical trial update describing a study focusing on patient-reported outcomes in advanced pancreatic cancer or non-small cell lung cancer t…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer [Phase 1]
Phase 1 study evaluating pulse radiotherapy to overcome metastatic immune system evasion in non-small cell lung cancer; the trial status is …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Clinical trial update on detecting tumor cells and tumor DNA in blood, urine, and bone marrow of patients with solid cancers; the study is c…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Local Injection and Systemic Therapy in the Treatment of NSCLC. [Phase 2]
A Phase 2 clinical trial is described for treating Non-small cell lung cancer using local injection plus systemic therapy, with the study st…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial [Phase 2]
A Phase II multicenter trial is evaluating the efficacy of a PD-1 inhibitor in combination therapy for non-small cell lung cancer patients w…